Antimicrobial Drug–Selection Markers for Burkholderia pseudomallei and B. mallei
2008
Antimicrobial Drug-Selection Markers for Burkholderia pseudomallei and B. mallei
publication
Author Information
Author(s): Schweizer Herbert P., Peacock Sharon J.
Primary Institution: Colorado State University
Hypothesis
The study investigates the challenges and regulations surrounding the use of antimicrobial drug-selection markers for Burkholderia pseudomallei and B. mallei.
Conclusion
The lack of approved antimicrobial drug-selection markers hampers genetic research on Burkholderia pseudomallei and B. mallei.
Supporting Evidence
- Genetic research into Burkholderia pseudomallei and B. mallei is hindered by a lack of approved antimicrobial drug-selection markers.
- Strict regulations in the U.S. limit the use of certain genetic tools for these select agents.
- B. pseudomallei and B. mallei are intrinsically resistant to many antimicrobial drugs, complicating treatment and research.
Takeaway
Scientists need special markers to study certain bacteria, but there aren't enough approved ones, making research difficult.
Limitations
The study highlights the limited availability of genetic tools and the strict regulations that complicate research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website